Skip to main content

Seres Therapeutics, Inc.

MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001609809

In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Seres Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
123
−5 vs. Q1 2022
Shares held
90.9M
+15.5M (+20.6%) vs. Q1 2022
Total value
$312.7M
−$223.9M (−41.7%) vs. Q1 2022
New holders
18
35 more added
Sold out
23
49 more reduced

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MCRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 123 institutions
Q1 2021: 154 institutionsQ2 2021: 147 institutionsQ3 2021: 133 institutionsQ4 2021: 148 institutionsQ1 2022: 131 institutionsQ2 2022: 123 institutionsQ3 2022: 120 institutionsQ4 2022: 124 institutionsQ1 2023: 123 institutionsQ2 2023: 138 institutionsQ3 2023: 134 institutionsQ4 2023: 103 institutionsQ1 2024: 99 institutionsQ2 2024: 93 institutionsQ3 2024: 77 institutionsQ4 2024: 69 institutionsQ1 2025: 63 institutionsQ2 2025: 33 institutionsQ3 2025: 32 institutionsQ4 2025: 36 institutionsQ1 2026: 33 institutionsQ2 2026: 35 institutions
Value heldQ2 2022: $312.7M
Q1 2021: $1.85BQ2 2021: $1.93BQ3 2021: $555.1MQ4 2021: $642.8MQ1 2022: $537.2MQ2 2022: $312.7MQ3 2022: $671.6MQ4 2022: $588.2MQ1 2023: $593.9MQ2 2023: $538.1MQ3 2023: $255.6MQ4 2023: $125.4MQ1 2024: $66.3MQ2 2024: $50.0MQ3 2024: $60.1MQ4 2024: $52.5MQ1 2025: $43.1MQ2 2025: $25.4MQ3 2025: $40.9MQ4 2025: $36.4MQ1 2026: $20.5MQ2 2026: $17.9M
Institutions holding MCRB and their total value by quarter
QuarterHoldersValue
Q2 202635$17.9M
Q1 202633$20.5M
Q4 202536$36.4M
Q3 202532$40.9M
Q2 202533$25.4M
Q1 202563$43.1M
Q4 202469$52.5M
Q3 202477$60.1M
Q2 202493$50.0M
Q1 202499$66.3M
Q4 2023103$125.4M
Q3 2023134$255.6M
Q2 2023138$538.1M
Q1 2023123$593.9M
Q4 2022124$588.2M
Q3 2022120$671.6M
Q2 2022123$312.7M
Q1 2022131$537.2M
Q4 2021148$642.8M
Q3 2021133$555.1M
Q2 2021147$1.93B
Q1 2021154$1.85B

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Seres Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding MCRB in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Goldman Sachs Group Inc471,548$1.62M0.00%−157,001−25.0%Reduced
Jacobs Levy Equity Management, Inc475,121$1.63M0.01%−465,010−49.5%Reduced
Ikarian Capital, LLC540,624$1.85M0.77%−300,000−35.7%Reduced
Dimensional Fund Advisors LP542,755$1.86M0.00%+74,444+15.9%Added
Price T Rowe Associates Inc568,709$1.95M0.00%+500+0.1%Added
Northern Trust Corp676,808$2.32M0.00%−23,946−3.4%Reduced
Nikko Asset Management Americas, Inc.696,785$2.34M0.03%−30,473−4.2%Reduced
Sumitomo Mitsui Trust Holdings, Inc.696,785$2.39M0.00%−30,473−4.2%Reduced
Hudson Bay Capital Management LP722,100$2.48M0.02%+572,100+381.4%Added
Lion Point Capital, LP481,803$2.66M0.94%00.0%Unchanged
JPMorgan Chase & Co780,844$2.68M0.00%+638,779+449.6%Added
Renaissance Technologies LLC876,407$3.01M0.00%+397,007+82.8%Added
Millennium Management LLC1,093,910$3.75M0.00%+504,624+85.6%Added
Maven Securities LTD1,154,507$3.96M0.70%+1,154,507New
Geode Capital Management, LLC1,218,748$4.18M0.00%+9,431+0.8%Added
State Street Corp1,464,345$5.02M0.00%−3,383,598−69.8%Reduced
CVI Holdings, LLC2,722,826$9.34M0.68%+2,722,826New
Vanguard Group Inc5,330,817$18.3M0.00%+263,887+5.2%Added
Janus Henderson Group PLC5,370,409$18.4M0.01%−436,271−7.5%Reduced
BlackRock Inc.5,760,733$19.8M0.00%−133,697−2.3%Reduced
Flagship Pioneering Inc.14,378,802$49.3M1.86%00.0%Unchanged
Federated Hermes, Inc.17,982,256$61.7M0.17%+9,971,450+124.5%Added
FMR LLC18,601,212$63.8M0.01%+4,723,347+34.0%Added
Soviero Asset Management, LP0$00.00%−360,000−100.0%Sold out
Adage Capital Partners GP, L.L.C.0$00.00%−300,000−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−296,435−100.0%Sold out
Putnam Investments LLC0$00.00%−194,782−100.0%Sold out
Oregon Public Employees Retirement Fund0$00.00%−89,274−100.0%Sold out
American Century Companies Inc0$00.00%−75,410−100.0%Sold out
Edgewood Management LLC0$00.00%−70,000−100.0%Sold out
DekaBank Deutsche Girozentrale0$00.00%−67,000−100.0%Sold out
Engineers Gate Manager LP0$00.00%−56,974−100.0%Sold out
Jane Street Group, LLC0$00.00%−19,160−100.0%Sold out
Trexquant Investment LP0$00.00%−17,719−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−14,871−100.0%Sold out
Blueshift Asset Management, LLC0$00.00%−10,294−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−519−100.0%Sold out
US Bancorp0$00.00%−249−100.0%Sold out
Kayne Anderson Rudnick Investment Management LLC0$00.00%−247−100.0%Sold out
Massmutual Trust Co FSB0$00.00%−349−100.0%Sold out
Signaturefd, LLC0$00.00%−327−100.0%Sold out
CWM, LLC0$00.00%−225−100.0%Sold out
Bessemer Group Inc0$00.00%−139−100.0%Sold out
Captrust Financial Advisors0$00.00%−101−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−87−100.0%Sold out
Capital Advisors, Ltd. LLC0$00.00%−11−100.0%Sold out
Susquehanna Fundamental Investments, LLC––––Not filed
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed